Beovu

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Diabetic Macular EdemaNeovascular Age-related Macular Degeneration

Unknown Phase

A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

CompletedNCT04632056

Novartis PharmaceuticalsNeovascular Age-related Macular Degeneration

Start: 2020-11-16End: 2022-11-10Updated: 2023-11-14

Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

CompletedNCT05526729

Novartis PharmaceuticalsDiabetic Macular Edema

Start: 2022-09-02End: 2024-06-29Updated: 2025-06-13